Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES BIOCON ZYDUS LIFESCIENCES/
BIOCON
 
P/E (TTM) x 34.2 19.7 174.0% View Chart
P/BV x 5.8 1.8 320.4% View Chart
Dividend Yield % 0.6 0.6 105.1%  

Financials

 ZYDUS LIFESCIENCES   BIOCON
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
BIOCON
Mar-23
ZYDUS LIFESCIENCES/
BIOCON
5-Yr Chart
Click to enlarge
High Rs495388 127.6%   
Low Rs319192 166.7%   
Sales per share (Unadj.) Rs170.393.1 183.0%  
Earnings per share (Unadj.) Rs19.85.4 369.3%  
Cash flow per share (Unadj.) Rs26.914.6 184.0%  
Dividends per share (Unadj.) Rs6.001.50 400.0%  
Avg Dividend yield %1.50.5 284.6%  
Book value per share (Unadj.) Rs173.0146.5 118.1%  
Shares outstanding (eoy) m1,012.201,200.60 84.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.43.1 76.8%   
Avg P/E ratio x20.654.1 38.1%  
P/CF ratio (eoy) x15.119.8 76.4%  
Price / Book Value ratio x2.42.0 119.0%  
Dividend payout %30.328.0 108.3%   
Avg Mkt Cap Rs m412,144347,814 118.5%   
No. of employees `000NANA-   
Total wages/salary Rs m24,56421,810 112.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,374111,742 154.3%  
Other income Rs m4,7467,681 61.8%   
Total revenues Rs m177,120119,423 148.3%   
Gross profit Rs m29,67716,611 178.7%  
Depreciation Rs m7,22711,131 64.9%   
Interest Rs m1,2994,190 31.0%   
Profit before tax Rs m25,8978,971 288.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,8782,541 231.3%   
Profit after tax Rs m20,0196,430 311.3%  
Gross profit margin %17.214.9 115.8%  
Effective tax rate %22.728.3 80.1%   
Net profit margin %11.65.8 201.8%  
BALANCE SHEET DATA
Current assets Rs m100,082123,340 81.1%   
Current liabilities Rs m55,26785,107 64.9%   
Net working cap to sales %26.034.2 76.0%  
Current ratio x1.81.4 125.0%  
Inventory Days Days50129 39.0%  
Debtors Days Days94117 80.1%  
Net fixed assets Rs m144,776394,078 36.7%   
Share capital Rs m1,0126,003 16.9%   
"Free" reserves Rs m174,146169,926 102.5%   
Net worth Rs m175,158175,929 99.6%   
Long term debt Rs m0152,905 0.0%   
Total assets Rs m244,940517,418 47.3%  
Interest coverage x20.93.1 666.5%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x0.70.2 325.9%   
Return on assets %8.72.1 424.0%  
Return on equity %11.43.7 312.7%  
Return on capital %15.54.0 387.9%  
Exports to sales %39.23.1 1,263.5%   
Imports to sales %11.96.0 200.1%   
Exports (fob) Rs m67,5773,467 1,949.1%   
Imports (cif) Rs m20,5446,654 308.7%   
Fx inflow Rs m67,5773,467 1,949.1%   
Fx outflow Rs m20,5446,654 308.7%   
Net fx Rs m47,033-3,187 -1,475.8%   
CASH FLOW
From Operations Rs m26,88818,525 145.1%  
From Investments Rs m11,712-142,818 -8.2%  
From Financial Activity Rs m-44,004130,487 -33.7%  
Net Cashflow Rs m-5,3386,411 -83.3%  

Share Holding

Indian Promoters % 75.0 40.4 185.8%  
Foreign collaborators % 0.0 20.3 -  
Indian inst/Mut Fund % 18.0 21.1 85.6%  
FIIs % 5.0 6.6 76.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 39.4 63.6%  
Shareholders   306,495 434,339 70.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Biocon Share Price Performance

Period Cadila Healthcare Biocon S&P BSE HEALTHCARE
1-Day 0.57% 2.92% 1.18%
1-Month 7.77% -2.53% -0.75%
1-Year 107.52% 30.52% 61.82%
3-Year CAGR 32.30% -13.55% 18.16%
5-Year CAGR 24.52% -2.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.